Separate-Vial Reconstitution Spec BAC water added BPC-157 (10 mg vial) 2.0 mL TB-500 (10 mg vial) 2.0 mL Spec Final concentration BPC-157 (10 mg vial) 5.0 mg/mL TB-500 (10 mg vial) 5.0 mg/mL Spec 10 units (0.10 mL) delivers BPC-157 (10 mg vial) 500 mcg TB-500 (10 mg vial) 500 mcg Spec 20 units (0.20 mL) delivers BPC-157 (10 mg vial) 1.0 mg TB-500 (10 mg vial) 1.0 mg Spec Doses per vial (typical) BPC-157 (10 mg vial) ~2040 days TB-500 (10 mg vial) ~45 loading doses This separate-vial row keeps the same 10 mg-per-compound assumption as the 20 mg pre-blend, but the compounds are reconstituted and drawn independently
As a highlight, BPC 157 as a neurotransmitter (or as neurotransmitter-like) can offer a network of interconnected evidence [6,9] previously envisaged in the implementation of cytoprotection effects (i.e., a cytoprotection mediator holds a response specifically related to preventing or recovering damage as such [41])
During this phase, injection frequency is higher to build systemic levels of the peptide and begin the actin regulation and angiogenesis responses
For product information, view BPC-157 | UK Stock | Research Peptide
Cannon B, Nedergaard J
Severe edema stresses your heart, blood vessels, lungs, and other organs, though thats more common with direct HGH supplementation